International Journal of Radiation Oncology*Biology*Physics
Clinical InvestigationPopulation-Based Study of Trends and Variations in Radiotherapy as Part of Primary Treatment of Cancer in the Southern Netherlands Between 1988 and 2006, With an Emphasis on Breast and Rectal Cancer
Introduction
It is estimated that about 50% of all patients with cancer receive radiotherapy (RT) during the course of their treatment (1). This percentage is based on expert analysis and is often used to guide decisions about current and future needs for RT equipment and personnel. Factored into this planning is the reasoning that primary RT is usually part of initial treatment and that secondary RT is part of the treatment for recurrent disease or metastases 1, 2, irrespective of whether patients have already received primary RT. However, population-based studies done in the southern Netherlands showed that only about 30% of all cancer patients received primary RT during the years 1975 to 2002 3, 4, 5. Furthermore, other studies showed that 67% of all patients with breast cancer and 45% of all patients with rectal cancer received RT (primary or secondary) in the first 5 years after diagnosis 6, 7.
In addition, between 1988 and 1999, referral for primary RT from hospital to hospital varied substantially in our region (8). The same was true for other regions of the Netherlands and for the United States as well, especially for patients with breast cancer 9, 10. These variations in the use of RT, and the fact that these earlier percentages departed from the 50% predicted use, prompted us to conduct subsequent studies of the use of primary RT for different tumor types to determine whether there has been improved adherence to guidelines that have been disseminated at the national level in the Netherlands.
In the study reported here, we estimated the proportion of all cancer patients who received primary RT, and we determined the more in-depth trends and variations in the use of primary RT for patients with primary breast and rectal cancer newly diagnosed between 1988 and 2006 in the southern Netherlands.
Section snippets
Methods and Materials
Data were derived from the Eindhoven Cancer Registry (ECR), which contains data on all patients newly diagnosed with cancer since 1955. The registry covers a large part of the southern Netherlands, which had approximately 2.4 million inhabitants in 2004. The medical infrastructure consists of six pathology departments, 10 general hospitals (decreased from 20 hospitals 25 years ago), and two large RT departments, one in the west in Tilburg that operates as an independent facility (currently with
Total patient population
The annual number of patients with newly diagnosed cancer increased by 73%, from 5,479 patients in 1988 to 9,469 patients in 2006; the number of RT-treated patients increased from 1,668 to 2,971 over the same period, for an absolute increase of 78%. The annual percentage of patients receiving primary RT fluctuated between 30% and 32%, remaining at 30% in the western sector and becoming 35% in the eastern sector in the period 2003 to 2006 (Table 1). Patients older than 75 years in both regions
Total population
Although the total number of cancer patients and the number of RT-treated patients both increased substantially during the period 1988 to 2006 (19), the percentage of patients who received RT as part of their primary treatment remained stable at about 30%. However, it is important to bear in mind that this apparently stable percentage actually reflects a rising percentage of RT-treated patients with prostate and rectal cancer and a decreasing percentage of RT-treated patients with lung and
Conclusion
Although the absolute number of RT-treated patients with cancer increased substantially during 1988–2006, the proportion of patients referred for RT remained essentially unchanged in the southern Netherlands. However, substantial variations were found in referral rates for RT, especially in later years, between the eastern and the western sectors of the region, each with their own RT departments and referring hospitals. The unanswered question is whether this divergence might have been greater
References (52)
- et al.
Infrastructure for radiotherapy in the Netherlands: Development from 1970 to 2010
Int J Radiat Oncol Biol Phys
(1997) - et al.
Stable overall referral rates of primary radiotherapy for newly diagnosed cancer patients in the ageing population of South-Eastern Netherlands, 1975-1998
Radiother Oncol
(2004) - et al.
Referral rates and trends in radiotherapy as part of primary treatment of cancer in South Netherlands, 1988–2002
Radiother Oncol
(2006) - et al.
A population based study of radiotherapy in a cohort of patients with breast cancer diagnosed between 1996 and 2000
Eur J Cancer
(2007) - et al.
A population-based study of radiotherapy in a cohort of patients with rectal cancer diagnosed between 1996 and 2000
Eur J Surg Oncol
(2007) - et al.
Hospital variation in referral for primary radiotherapy in South Netherlands, 1988–1999
Eur J Cancer
(2005) - et al.
Explanatory factors for variation in the use of breast conserving surgery and radiotherapy in the Netherlands, 1990–2001
Breast
(2007) - et al.
Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of the Netherlands in 1993–1996
J Clin Epidemiol
(1999) - et al.
Controversies of total mesorectal excision for rectal cancer in elderly patients
Lancet Oncol
(2008) - et al.
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma
Lancet
(2000)
Postoperative radiotherapy for endometrial carcinoma. Stage I. Wide variation in referral patterns but no effect on long-term survival in a retrospective study in the southeast Netherlands
Eur J Cancer
Impact of external beam adjuvant radiotherapy on health-related quality of life for long-term survivors of endometrial adenocarcinoma: A population-based study
Int J Radiat Oncol Biol Phys
Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis
Lancet
Why patients choose prostatectomy or brachytherapy for localized prostate cancer: Results of a descriptive survey
Urology
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85-31
Int J Radiat Oncol Biol Phys
Breast conservation is the treatment of choice in small breast cancer: Long-term results of a randomized trial
Eur J Cancer
The introduction of mammographical screening has had little effect on the trend in breast-conserving surgery: A population-based study in Southeast Netherlands
Eur J Cancer
The impact of comorbidities on outcomes for elderly women treated with breast-conservation treatment for early-stage breast cancer
Int J Radiat Oncol Biol Phys
Breast cancer in elderly women: Can radiotherapy be omitted?
Eur J Cancer
Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials
Radiother Oncol
Use of postmastectomy radiotherapy in older women
Int J Radiat Oncol Biol Phys
Improved survival of patients with rectal cancer since 1980: A population-based study
Eur J Cancer
Survival of elderly rectal cancer patients not improved: Analysis of population based data on the impact of TME surgery
Eur J Cancer
Should radiotherapy be avoided or delivered differently in elderly patients with rectal cancer?
Eur J Cancer
A prospective survey of radiotherapy practice 2001 in Sweden
Acta Oncol
Patterns of radiotherapy for cancer patients in south-eastern Netherlands, 1975–1989
Radiother Oncol
Cited by (15)
Quality assurance standards drive improvements in the profile of radiation therapy departments participating in trials of the EORTC Radiation Oncology Group
2014, Radiotherapy and OncologyCitation Excerpt :Sufficient physical capacity needs to be balanced against increased throughput with modern dedicated equipment. Within Europe and the rest of the world there is a wide variety of radiation therapy staffing and equipment guidelines designed for resource planning and expansion [7–11]. Each of these guidelines attempts to assess how current radiation therapy capacity meets predicted need and goes on to suggest a model of planning future capacity development.
Feasibility of radiation therapy in patients 90 years of age and older: A French multicentre analysis
2014, European Journal of CancerCharacterization and adequacy of the use of radiotherapy and its trend in time
2013, Radiotherapy and OncologyCitation Excerpt :Finally, there is no scientific argument that supports radiation sub-indications in esophageal and lung cancer. This low rate is in the same range (slightly lower) as those described in southern Holland [7], although it is clearly lower than those reported by areas of excellence and EBEST groups. This decline is also found in other population studies [7] and has been associated with an increase in the use of CH [21].
Epidemiologic Study of Radiotherapy Use in China in Patients with Breast Cancer between 1999 and 2008
2013, Clinical Breast CancerImaging of Recurrent Prostate Cancer
2012, Radiologic Clinics of North AmericaCitation Excerpt :Patients with biochemical recurrence after radical prostatectomy have an 88% 10-year overall survival rate compared with a 93% in men without signs of biochemical recurrence.7 Approximately 25% to 30% of patients with newly diagnosed prostate cancer undergo external beam radiation therapy (EBRT) as their definitive treatment.8–10 Unfortunately, up to 50% of patients develop biochemical failure, presumably caused by local recurrence after 5 years.11–15
Conflict of interest: none.